The fabrication process of micropatterned alloy and nanofibers is shown in Scheme 1. The photomask, master wafer, and PDMS mold were prepared using standard photolithography in Cornell NanoScale Science & Technology Facility. Briefly, the photomask was prepared using a mask writer (DWL2000, Heidelberg Instruments). The silicon wafer was spin-coated with SU-8 2150 photoresist (MicroChem) at 500 rpm for 40 sec and then 2500 rpm for 30 sec. The wafer was covered with the photomask and exposed by a UV photolithography machine (ABM Contact
2 Aligner) for 32 sec. After being developed and post-baked, the SU-8 master wafer was fabricated. The SU-8 master wafer was then used to create PDMS (Sylgard 184, Dow Corning) mold. A mixture (10:1) of Sylgard 184 silicone elastomer components was casted onto the master wafer and cured at 60 °C overnight to prepare a PDMS mold. The PDMS molds were photographed using an optical microscope (EVOS, AMG).
To fabricate micropatterned alloy (melting temperature: 62 °C, Rotometals, Inc.), a PDMS mold was placed and pressed on melt alloy in an 80 °C oven. At room temperature (RT), the alloy solidified and geometrical micropatterns were transferred from PDMS mold to alloy surface. The micropatterns on alloy were photographed using an optical microscope (BX-51, Olympus). For electrospinning nylon nanofibers, a precursor solution of 20% (w/v) nylon 6 (Scientific Polymer Products, Inc) in formic acid (Sigma) was prepared. A 16G blunt needle (Sai Infusion Technologies) was used as the spinneret. The nanofibers were electrospun at 20 kV (ES40P-10W, Gamma High Voltage) with a pumping rate of 0.001 mL min -1 (70-2000, Harvard Apparatus) and collected on micropatterned alloy. The working distance was fixed at 25 cm. The free-standing micropatterned nanofibrous membranes were obtained after being peeled off from the alloy and characterized with an optical microscope (EVOS, AMG) and scanning electron microscope (SEM, LEO 1550).
Preparation of nanofibers-framed hydrogel micropatterns
Alginate solution (1.5%, w/v, FMC Biopolymer) was spread over micropatterned nanofibers on the alloy and crosslinked with CaCl 2 (100 mM)-BaCl 2 (5 mM) solution through a dialysis membrane (MWCO: 12,000 ~ 14,000, Spectro/Por ® , Spectrum Laboratories, Inc.) placed on top of the alginate solution. After crosslinking, the membrane was removed and the nanofibers-framed hydrogel micropattern was peeled off from the alloy (Scheme 1). The alginate/fibrin hydrogel was composed of 1% alginate, 2.5 mg/mL fibrinogen (Sigma), and 1 U/mL thrombin (Sigma). The nanofibers were pre-loaded with red rhodamine and the alginate was chemically labeled with a green Alexa Fluor ® 488 dye for fluorescence microscope characterization.
Cell culture and encapsulation in nanofibers-framed hydrogel micropatterns
INS-1 832/13 cells were cultured in RPMI 1640 medium (Gibco) supplemented with 2 mM glutamine (Gibco), 1 mM sodium pyruvate (Gibco), 10% fetal bovine serum (FBS, Gibco), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, Sigma), 100 units/mL penicillin (Gibco), 100 µg/mL streptomycin (Gibco), 250 ng/mL amphotericin B (Gibco), and 50 µM β-mercaptoethanol (Gibco). MDA-MB-231-GFP cells and normal human lung fibroblasts (NHLF) expressing RFP proteins were cultured in DMEM medium (Gibco) supplemented with 2 mM glutamine (Gibco), 10% fetal bovine serum (FBS, Gibco), 100 units/mL penicillin (Gibco), and 100 µg/mL streptomycin (Gibco). Human umbilical vein endothelial cells (HUVECs)
expressing GFP proteins were cultured in EGM-2 medium (Lonza). Cells were plated at a density of ~ 10,000 cells/cm 2 and grown at 37 °C and 5% CO 2 incubator to ~80% confluence over ~ 5 days prior to encapsulation experiment.
To differentiate to pancreatic progenitors (PPs), human embryonic stem cells (hESCs, HUES8) were cultured on irradiated mouse embryonic fibroblast feeders to 80-90% confluency, then treated with 3 µM CHIR99021 (CHIR, Stem-RD) and 100 ng/ml activin A (R&D systems)
in RPMI medium (Cellgro) supplemented with 2 mM GlutaMAX (Gibco) and 100 U/ml Pen/Strep (Gibco) for one day, and then 100 ng/ml activin A in RPMI medium supplemented with 0.2% FBS, 2 mM GlutaMAX and 100 U/ml Pen/Strep. The medium was changed 2 days later to 50 ng/ml FGF7 (PeproTech) in RPMI medium supplemented with 2 mM GlutaMAX, 100 U/ml Pen/Strep and 2% FBS, and maintained for an additional 2 days. Cells were transferred to 300 nM LDN193189 (LDN, Axon), 2 µM retinoic acid (Sigma), and 0.25 µM SANT-1 (Sigma) for the first 4 days and then to 300 nM LDN193189 (LDN, Axon), 20 nM Phorbol 12,13-dibutyrate (PuBu, Sigma), and 1 µM ALK5i (Enzo) in DMEM medium supplemented with 2 mM GlutaMAX, 100 U/ml Pen/Strep, and 1× B27 (Invitrogen) for an additional 4 days.
At this stage, hESCs-derived cells containing a high percentage PDX1 + cells are defined as the hESCs-PPs. For immunocytochemistry, cells were fixed in 10% formalin for 20 min at room temperature. Non-specific antigen and antibody association were blocked in 5% horse serum (Invitrogen), 0.3% Triton X in PBS for 1 h at room temperature, followed by primary antibody incubation overnight. The following antibodies were used: goat anti-PDX1 (1:500, R&D systems), and goat anti-SOX9 (1:1000, Abcam). This was followed by incubation with speciesappropriate secondary antibodies. Cell nuclear was counterstained with DAPI. and a composite nanofibers-framed hydrogel micropattern (b). Scale bars: 1 cm.
